Sedana Medical AB (publ) / Fundamentals
Income statement
- Net revenue
€17.81M - Cost of goods sold
€5.28M - Gross profit
€12.53M - SG&A expenses
€14.30M - R&D expenses
€1.86M - EBITDA
-€1.72M - D&A
€1.96M - EBIT
-€3.64M - Interest expenses
€965.04K - EBT
-€4.46M - Tax expenses
€152.82K - Net income
-€4.62M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€1.21M - Changes in working capital
-€2.08M - Operating cash flow
-€2.59M - Capex
€9.29M - Other investing cash flow
-€8.94M - Net investing cash flow
-€11.55M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
-€355.13K - Net financing cash flow
-€355.13K - Foreign exchange effects
-€1.27M - Net change in cash
-€15.76M - Cash at end of period
€11.87M - Free cash flow
€6.70M
Balance sheet
- Cash and cash equivalents
€11.87M - Cash and short-term investments
€11.87M - Total receivables
€3.79M - Inventory
€3.64M - Other current assets
€316.72K - Total current assets
€19.61M - Property, plant & equipment
€798.60K - Goodwill
€2.28M - Intangible assets
€66.19M - Long-term investments
€0.00 - Other non-current assets
€4.27K - Total non-current assets
€69.27M - Total assets
€88.88M - Accounts payable
€474.89K - Short-term debt
€480.89K - Other current liabilities
€3.05M - Total current liabilities
€4.30M - Long-term debt
€201.85K - Deferred tax liabilities
€70.73K - Other non-current liabilities
€750.93K - Total non-current liabilities
€1.02M - Total liabilities
€5.33M - Common stock
€225.46K - Retained earnings
-€27.63M - Other equity
€0.00 - Total equity
€83.56M - Total liabilities and shareholders' equity
€88.88M
Company information
- Market capitalization
€96.97M - Employees
113 - Enterprise Value
€910.60M
Company ratios
- Gross margin
-
70.4% Worse than peer group: 80.4% - EBITDA margin
-
-9.6% Much better than peer group: -175.1% - EBIT margin
-
-20.4% Much better than peer group: -211.0% - EBT margin
-
-25.1% Much better than peer group: -209.4% - Net margin
-
-25.9% Much better than peer group: -210.4% - ROE
-
-5.5% Better than peer group: -12.8% - ROA
-
-5.2% Much better than peer group: -34.6% - Asset turnover
-
20.0% Worse than peer group: 38.8% - FCF margin
-
-66.7% Much better than peer group: -203.5% - FCF yield
-12.2% - Efficiency ratio
109.6% - Net sales per employee
-
€157.60K - Net income per employee
-
-€40.86K